Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5191)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,235
Price
$573.39
Total Value
$708.13K
Shares Held After
46,873
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
945
Price
$572.39
Total Value
$540.91K
Shares Held After
48,108
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
925
Price
$571.39
Total Value
$528.53K
Shares Held After
49,053
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
35
Price
$569.78
Total Value
$19.94K
Shares Held After
49,978
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
9,165
Price
$34.97
Total Value
$320.54K
Shares Held After
276,851
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$580.03
Total Value
$23.20K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$579.04
Total Value
$231.62K
Shares Held After
18,916
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
601
Price
$577.93
Total Value
$347.33K
Shares Held After
19,316
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,603
Price
$577.01
Total Value
$924.95K
Shares Held After
19,917
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,354
Price
$575.96
Total Value
$779.84K
Shares Held After
21,520
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,457
Price
$575.06
Total Value
$837.86K
Shares Held After
22,874
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,860
Price
$574.00
Total Value
$1.07M
Shares Held After
24,331
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,210
Price
$572.96
Total Value
$693.28K
Shares Held After
26,191
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,154
Price
$571.76
Total Value
$659.81K
Shares Held After
27,401
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$571.14
Total Value
$160.49K
Shares Held After
28,555
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$569.61
Total Value
$22.78K
Shares Held After
28,836
% of Holdings
0.1%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
33,171
Price
$6.41
Total Value
$212.76K
Shares Held After
49,849
% of Holdings
40.0%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
3,400
Price
$4.76
Total Value
$16.20K
Shares Held After
268,596
% of Holdings
1.3%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
1,000
Price
$4.76
Total Value
$4.76K
Shares Held After
271,996
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
3,400
Price
$4.76
Total Value
$16.20K
Shares Held After
632,096
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
1,014
Price
$4.76
Total Value
$4.83K
Shares Held After
635,496
% of Holdings
0.2%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
4,442
Price
$4.76
Total Value
$21.17K
Shares Held After
685,232
% of Holdings
0.6%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
4,399
Price
$4.76
Total Value
$20.96K
Shares Held After
3,707,569
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,338
Price
$14.08
Total Value
$47.00K
Shares Held After
421,174
% of Holdings
0.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
15,722
Price
$12.95
Total Value
$203.60K
Shares Held After
424,512
% of Holdings
3.6%
Alignment Healthcare, Inc. (ALHC)
KAO JOHN E — Director
Shares
82,299
Price
$20.80
Total Value
$1.71M
Shares Held After
1,806,641
% of Holdings
4.4%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$77.95
Total Value
$38.98K
Shares Held After
78,890
% of Holdings
0.6%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
22,562
Price
$26.72
Total Value
$602.86K
Shares Held After
549,163
% of Holdings
3.9%
Doximity, Inc. (DOCS)
Sitaram Siddharth — Interim PFO and PAO
Shares
2,427
Price
$21.09
Total Value
$51.19K
Shares Held After
86,705
% of Holdings
2.7%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
21,433
Price
$40.12
Total Value
$859.88K
Shares Held After
1,495,234
% of Holdings
1.4%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
23,821
Price
$40.14
Total Value
$956.25K
Shares Held After
411,855
% of Holdings
5.5%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$6.20
Total Value
$49.60K
Shares Held After
70,405
% of Holdings
11.4%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
500
Price
$34.98
Total Value
$17.49K
Shares Held After
286,016
% of Holdings
0.2%
VEEVA SYSTEMS INC (VEEV)
Hung Priscilla — Director
Shares
750
Price
$153.50
Total Value
$115.12K
Shares Held After
4,003
% of Holdings
15.8%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
32
Price
$120.23
Total Value
$3.85K
Shares Held After
90,370
% of Holdings
0.0%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
614
Price
$119.35
Total Value
$73.28K
Shares Held After
90,402
% of Holdings
0.7%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
210
Price
$117.45
Total Value
$24.66K
Shares Held After
91,016
% of Holdings
0.2%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
1,237
Price
$116.72
Total Value
$144.38K
Shares Held After
91,226
% of Holdings
1.3%
electroCore, Inc. (ECOR)
Goldberger Daniel S — Former Officer and Director
Shares
16,072
Price
$6.02
Total Value
$96.75K
Shares Held After
291,471
% of Holdings
5.2%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
2,400
Price
$4.67
Total Value
$11.20K
Shares Held After
346,420
% of Holdings
0.7%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
3,725
Price
$4.68
Total Value
$17.44K
Shares Held After
272,996
% of Holdings
1.3%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
3,706
Price
$4.68
Total Value
$17.35K
Shares Held After
636,510
% of Holdings
0.6%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
3,687
Price
$4.69
Total Value
$17.28K
Shares Held After
689,674
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
3,732
Price
$4.72
Total Value
$17.61K
Shares Held After
3,711,968
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
8,500
Price
$4.72
Total Value
$40.10K
Shares Held After
3,715,700
% of Holdings
0.2%
908 Devices Inc. (MASS)
McCallion Kevin J. — SVP, Products and Production
Shares
2,693
Price
$7.01
Total Value
$18.88K
Shares Held After
44,925
% of Holdings
5.7%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
6,596
Price
$3.43
Total Value
$22.62K
Shares Held After
515,955
% of Holdings
1.3%
Phreesia, Inc. (PHR)
Hoffman Allison C — General Counsel & Secretary
Shares
14,483
Price
$8.07
Total Value
$116.88K
Shares Held After
163,485
% of Holdings
8.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
400
Price
$13.48
Total Value
$5.39K
Shares Held After
425,512
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
18,660
Price
$12.75
Total Value
$237.91K
Shares Held After
425,912
% of Holdings
4.2%
Showing 3201–3250 of 5191 transactions (page 65 of 104)